United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Sep 25, 2026 · Filed Sep 28, 2026

On Sep 25, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$476.17 for US$4.52M under a trading plan, leaving 324,443 shares. Filed Sep 28, 2026 (Form 4).

Sold
9,500 shares
Price
US$476.17 average (US$470.56 to US$478.95)
Value
US$4.52M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 25, 2026Common StockOption exercise9,500US$117.76333,943Indirect
Sep 25, 2026Common StockSale40US$470.56333,903Indirect
Sep 25, 2026Common StockSale200US$471.84333,703Indirect
Sep 25, 2026Common StockSale800US$472.89332,903Indirect
Sep 25, 2026Common StockSale543US$474.15332,360Indirect
Sep 25, 2026Common StockSale1,613US$475.28330,747Indirect
Sep 25, 2026Common StockSale2,744US$476.13328,003Indirect
Sep 25, 2026Common StockSale1,280US$477.19326,723Indirect
Sep 25, 2026Common StockSale1,648US$478.18325,075Indirect
Sep 25, 2026Common StockSale632US$478.95324,443Indirect

Source

View original at SEC

Related